http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-201300006-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2013-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d44dcfcfccd3f952ac202b369cfedee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a5ec634cb482dc2d05aa67f9d44180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8db6752dbf39af899bcd8ae2be7f1206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d04acb1d607c1c7af2a1193f62e0352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81b6dc4d8cd6f38677de580478864700
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_231b339347b2c6b2c9e1ddef0d8889e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_116b78b1e2a871c46026570c146a7667
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81bcc9a1836af7e2018cdc64c0b825f5
publicationDate 2014-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-201300006-A
titleOfInvention THERAPENTUTIC AGENTS 976
abstract THIS INVENTION REFERS TO CERTAIN SUBSTITUTED COMPOUNDS OF (3- (4- (AMINOMETIL) PHENOXY OR PHENYLITIO) AZETIDIN-1-IL) (5-PHENYL-1,3,4-OXADIAZOL-2-IL) METHANONE OF FORMULA I , TO PROCESSES TO PREPARE SUCH COMPOUNDS, FOR USE IN THE TREATMENT OF A DISEASE OR AFFECTION RELATED TO MELANINE CONCENTRATING HORMONE, FOR EXAMPLE, OBESITY, AFFECTIONS RELATED TO OBESITY, ANXIETY AND DEPRESSION, AND TO COMPOSITIONS THAT CONTAIN THEM.
priorityDate 2010-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12485890

Total number of triples: 34.